• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2型糖尿病药物筛选技术的研究进展]

[Research progress of the drug screening technology in type 2 diabetes mellitus].

作者信息

Luo Aoxue, Fan Yijun, Luo Aoshuang, Song Guanbin

机构信息

College of Bioengineering, Chongqing University, Chongqing 400044, China.

出版信息

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006 Aug;23(4):895-8.

PMID:17002133
Abstract

With the incidence of type 2 diabetes mellitus increasing year after year, the technology of drug screening of type 2 diabetes mellitus progress rapidly, from the level of animal screening to cellular and molecular screening model, from the traditional drug screening technology to high efficient and throughput screening. This paper will summarize the technology of drug screening in the therapy of type 2 diabetes mellitus.

摘要

随着2型糖尿病的发病率逐年上升,2型糖尿病的药物筛选技术进展迅速,从动物筛选水平发展到细胞和分子筛选模型,从传统的药物筛选技术发展到高效和高通量筛选。本文将总结2型糖尿病治疗中的药物筛选技术。

相似文献

1
[Research progress of the drug screening technology in type 2 diabetes mellitus].[2型糖尿病药物筛选技术的研究进展]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006 Aug;23(4):895-8.
2
Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes.药物评价:罗格列酮,一种用于治疗2型糖尿病的新型口服疗法。
Curr Opin Investig Drugs. 2007 Apr;8(4):338-44.
3
[The role of high throughput screening in the early stage of drug research].[高通量筛选在药物研究早期阶段的作用]
Acta Pharm Hung. 2004;74(1):5-10.
4
Establishment of a cell-based drug screening model for identifying down-regulators of Protein Tyrosine Phosphatase 1B expression.建立用于鉴定蛋白酪氨酸磷酸酶1B表达下调调节剂的细胞药物筛选模型。
Exp Clin Endocrinol Diabetes. 2007 Jan;115(1):24-8. doi: 10.1055/s-2007-949590.
5
Putting the pieces together in diabetes research: towards a hierarchical model of whole-body glucose homeostasis.整合糖尿病研究的各个方面:迈向全身葡萄糖稳态的层次模型。
Eur J Pharm Sci. 2009 Jan 31;36(1):91-104. doi: 10.1016/j.ejps.2008.10.027. Epub 2008 Nov 13.
6
Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.((4R,5S)-5-氨基-4-(2,4,5-三氟苯基)环己-1-烯基)-(3-(三氟甲基)-5,6-二氢-[1,2,4]三唑并[4,3-a]吡嗪-7(8H)-基)甲酮(ABT-341)的发现,一种用于治疗2型糖尿病的高效、选择性、口服有效且安全的二肽基肽酶IV抑制剂。
J Med Chem. 2006 Nov 2;49(22):6439-42. doi: 10.1021/jm060955d.
7
[Measures to prevent or delay type 2 diabetes mellitus].[预防或延缓2型糖尿病的措施]
Ned Tijdschr Geneeskd. 2008 Jan 19;152(3):132-8.
8
Drug evaluation: PSN-9301, a short-acting inhibitor of dipeptidyl peptidase IV.
Curr Opin Investig Drugs. 2007 Apr;8(4):331-7.
9
Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.利用大鼠肝微粒体、氘标记的硬脂酰辅酶A和质谱法开发一种用于硬脂酰辅酶A去饱和酶的高通量筛选测定法。
Anal Chim Acta. 2008 Oct 3;627(1):105-11. doi: 10.1016/j.aca.2008.04.017. Epub 2008 Apr 15.
10
Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.肾葡萄糖重吸收抑制剂的研发:2型糖尿病药物治疗的新机制
J Med Chem. 2009 Apr 9;52(7):1785-94. doi: 10.1021/jm8013019.